Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry.

Sturgeon D, McCutcheon T, Geiger TM, Muldoon RL, Herline AJ, Wise PE.

Dis Colon Rectum. 2013 Mar;56(3):308-14. doi: 10.1097/DCR.0b013e31827edfff.

PMID:
23392144
2.

Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.

Maradiegue A, Jasperson K, Edwards QT, Lowstuter K, Weitzel J.

J Am Acad Nurse Pract. 2008 Feb;20(2):76-84. doi: 10.1111/j.1745-7599.2007.00282.x. Review.

PMID:
18271762
3.

Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.

Vasen HF, Velthuizen ME, Kleibeuker JH, Menko FH, Nagengast FM, Cats A, van der Meulen-de Jong AE, Breuning MH, Roukema AJ, van Leeuwen-Cornelisse I, de Vos Tot Nederveen Cappel WH, Wijnen JT.

Fam Cancer. 2016 Jul;15(3):429-35. doi: 10.1007/s10689-016-9897-1.

4.

Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist.

Daniels MS, Urbauer DL, Zangeneh A, Batte BA, Dempsey KM, Lu KH.

Gynecol Oncol. 2013 Dec;131(3):619-23. doi: 10.1016/j.ygyno.2013.10.011. Epub 2013 Oct 17.

5.

Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.

Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, Djordjevic B, Luthra R, Fellman BM, Lu KH, Broaddus RR.

Gynecol Oncol. 2014 Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14.

6.

Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

Stratton KL, Alanee S, Glogowski EA, Schrader KA, Rau-Murthy R, Klein R, Russo P, Coleman J, Offit K.

Urol Oncol. 2016 May;34(5):238.e1-7. doi: 10.1016/j.urolonc.2015.11.021. Epub 2015 Dec 23.

7.

Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.

Schofield L, Goldblatt J, Iacopetta B.

Rural Remote Health. 2011;11(4):1836. Epub 2011 Dec 22.

8.

Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.

Frolova AI, Babb SA, Zantow E, Hagemann AR, Powell MA, Thaker PH, Gao F, Mutch DG.

Gynecol Oncol. 2015 Apr;137(1):7-13. doi: 10.1016/j.ygyno.2015.01.535. Epub 2015 Jan 21.

9.

Performance of Lynch syndrome predictive models in a multi-center US referral population.

Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J.

Am J Gastroenterol. 2011 Oct;106(10):1822-7; quiz 1828. doi: 10.1038/ajg.2011.200. Epub 2011 Jul 12.

10.

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

BMC Cancer. 2015 Apr 25;15:313. doi: 10.1186/s12885-015-1254-5.

11.

Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.

Newton K, Green K, Lalloo F, Evans DG, Hill J.

Colorectal Dis. 2015 Jan;17(1):38-46. doi: 10.1111/codi.12778.

PMID:
25213040
12.

Defining the adenoma burden in lynch syndrome.

Kalady MF, Kravochuck SE, Heald B, Burke CA, Church JM.

Dis Colon Rectum. 2015 Apr;58(4):388-92. doi: 10.1097/DCR.0000000000000333.

PMID:
25751794
13.

Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome.

Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P.

Dtsch Arztebl Int. 2013 Jan;110(3):32-8. doi: 10.3238/arztebl.2013.0032. Epub 2013 Jan 18. Review.

14.

Genetic counseling and cascade genetic testing in Lynch syndrome.

Hampel H.

Fam Cancer. 2016 Jul;15(3):423-7. doi: 10.1007/s10689-016-9893-5.

PMID:
26969309
15.

Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.

Cohen SA, Laurino M, Bowen DJ, Upton MP, Pritchard C, Hisama F, Jarvik G, Fichera A, Sjoding B, Bennett RL, Naylor L, Jacobson A, Burke W, Grady WM.

Cancer. 2016 Feb 1;122(3):393-401. doi: 10.1002/cncr.29758. Epub 2015 Oct 19.

16.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

17.

Genetic testing by cancer site: colon (nonpolyposis syndromes).

Senter L.

Cancer J. 2012 Jul-Aug;18(4):334-7. doi: 10.1097/PPO.0b013e31826094b2. Review.

PMID:
22846734
18.

Lynch syndrome in South America: past, present and future.

Vaccaro CA, Sarroca C, Rossi B, Lopez-Kostner F, Dominguez M, Calo NC, Cutait R, Valle AD, Nuñez L, Neffa F, Alvarez K, Gonzalez ML, Kalfayan P, Lynch HT, Church J.

Fam Cancer. 2016 Jul;15(3):437-45. doi: 10.1007/s10689-016-9903-7.

PMID:
27007491
19.

Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

Green RC, Parfrey PS, Woods MO, Younghusband HB.

J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. doi: 10.1093/jnci/djn499. Epub 2009 Feb 24.

PMID:
19244167
20.

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.

Sharaf RN, Myer P, Stave CD, Diamond LC, Ladabaum U.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1093-100. doi: 10.1016/j.cgh.2013.04.044. Epub 2013 May 10. Review.

PMID:
23669308

Supplemental Content

Support Center